Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$6.95
-2.4%
$5.31
$3.96
$9.85
$2.61B0.412.62 million shs1.18 million shs
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$24.40
+0.2%
$23.30
$19.20
$25.83
N/AN/A127,756 shs112,684 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$80.97
-1.7%
$79.20
$73.31
$129.93
$203.22B0.3913.28 million shs7.73 million shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$10.07
-20.8%
$10.58
$8.79
$35.28
$4.41M0.9810,204 shs4,713 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
0.00%+7.99%+49.76%+30.25%-2.81%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00%+1.92%+3.92%+17.11%+3.74%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+2.58%+3.44%-0.63%-35.66%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00%+7.25%-4.05%+6.75%-67.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
3.1195 of 5 stars
0.93.00.04.02.53.30.6
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.9962 of 5 stars
3.23.05.04.23.02.53.8
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
1.86
Reduce$7.426.73% Upside
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00
N/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.43
Hold$109.1934.85% Upside
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest WEED, BHC, HIK, MRK, and EVT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Cautious
5/14/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$115.00 ➝ $84.00
5/2/2025
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$8.50 ➝ $10.00
4/22/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$85.00
4/17/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$115.00 ➝ $115.00
4/7/2025
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform$9.00 ➝ $8.50
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$9.63B0.27$7.64 per share0.91($0.89) per share-7.81
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$495.20MN/AN/AN/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$64.17B3.17$9.47 per share8.55$18.33 per share4.42
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
-$46M-$0.11N/A1.49N/A-0.41%-540.45%5.26%7/30/2025 (Estimated)
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$17.12B$6.8711.798.180.8427.27%43.23%17.11%7/29/2025 (Estimated)
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest WEED, BHC, HIK, MRK, and EVT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$0.9320N/AN/AN/A$2.47 billionN/A
7/29/2025Q2 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.03N/AN/AN/A$15.92 billionN/A
4/24/2025Q1 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.16$2.22+$0.06$2.01$15.59 billion$15.53 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
N/AN/AN/AN/AN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$1.978.07%N/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.244.00%N/A47.16%14 Years
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/A

Latest WEED, BHC, HIK, MRK, and EVT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/2/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.1%7/15/20257/15/20257/31/2025
5/27/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.814.18%6/16/20256/16/20257/8/2025
6/3/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.4%6/16/20256/16/20256/30/2025
5/2/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.7%5/15/20255/15/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
N/A
1.35
0.97
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.69
1.41
1.16
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20,700370.08 million340.29 millionOptionable
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/ANot Optionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.51 billion2.51 billionOptionable
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A375,000N/ANot Optionable

Recent News About These Companies

Top & Flop ETFs of the First Half of 2025
7 Best Marijuana Stocks and ETFs to Buy in 2025
6 Best-Performing ETFs of Last Week
Roundhill COIN WeeklyPay ETF (COIW)
Best & Worst ETF Zones of Q1
When (WEED) Moves Investors should Listen
(WEED) Pivots Trading Plans and Risk Controls
Top & Flop ETFs of 2024
(WEED) Long Term Investment Analysis
(WEED) Trading Advice
(WEED) Investment Analysis
(WEED) Investment Report
(WEED) Trading Signals
WEED Roundhill Cannabis ETF
(WEED) Trading Report
YBTC Sep 2024 43.000 put (YBTC240920P00043000)
Long Term Trading Analysis for (WEED)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bausch Health Cos stock logo

Bausch Health Cos NYSE:BHC

$6.95 -0.17 (-2.40%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$6.96 +0.01 (+0.09%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Eaton Vance Tax-Advantaged Dividend Income Fund NYSE:EVT

$24.40 +0.06 (+0.25%)
As of 07/3/2025 03:30 PM Eastern

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$80.97 -1.42 (-1.72%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$80.99 +0.02 (+0.02%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Roundhill Cannabis ETF stock logo

Roundhill Cannabis ETF BATS:WEED

$10.06 -2.64 (-20.79%)
As of 07/3/2025 12:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill.